Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2019

Jan 10, 2019

33003_dirs_2019-01-10_476757a9-fbeb-466c-a902-7d40559c7b73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-01-04

Reporting Person: Amorrortu Pedro Alvaro (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-01-04 Common Stock S 9000 $30.0688 Disposed 153746 Direct

Footnotes

F1: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2018.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.19, inclusive. The reporting person undertakes to provide to the issuer, any
security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.

F3: Amendment corrects arithmetical error as to number of securities in Column 5 of Table I.